Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
Organogenesis Holdings (Nasdaq: ORGO), a leading regenerative medicine company, has announced its participation in two upcoming investor conferences in September 2024. The company will attend:
1. The Morgan Stanley Global Healthcare Conference in New York, NY, where management will participate in investor 1x1 meetings without a formal presentation.
2. The Cantor Fitzgerald Global Healthcare Conference in New York, NY, featuring a fireside chat on September 18 at 1:20 p.m. Eastern Time. This presentation will be webcast and accessible via the company's website, with a replay available for approximately 30 days.
These conferences provide Organogenesis an opportunity to showcase its focus on developing, manufacturing, and commercializing product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets.
Organogenesis Holdings (Nasdaq: ORGO), una delle aziende leader nel campo della medicina rigenerativa, ha annunciato la sua partecipazione a due conferenze per investitori che si svolgeranno a settembre 2024. L'azienda parteciperà:
1. Alla Morgan Stanley Global Healthcare Conference a New York, NY, dove la direzione parteciperà a incontri con gli investitori one-to-one senza una presentazione formale.
2. Alla Cantor Fitzgerald Global Healthcare Conference a New York, NY, che include una chiacchierata informale il 18 settembre alle 13:20 ora orientale. Questa presentazione sarà trasmessa in streaming e sarà accessibile tramite il sito web dell'azienda, con una registrazione disponibile per circa 30 giorni.
Queste conferenze offrono a Organogenesis l'opportunità di mettere in mostra il suo impegno nello sviluppo, nella produzione e nella commercializzazione di soluzioni prodotte per i mercati della Cura Avanzata delle Ferite e della Medicina Chirurgica e Sportiva.
Organogenesis Holdings (Nasdaq: ORGO), una empresa líder en medicina regenerativa, ha anunciado su participación en dos conferencias para inversores que se llevarán a cabo en septiembre de 2024. La empresa asistirá:
1. A la Morgan Stanley Global Healthcare Conference en Nueva York, NY, donde la dirección participará en reuniones uno a uno con inversores sin una presentación formal.
2. A la Cantor Fitzgerald Global Healthcare Conference en Nueva York, NY, que contará con una charla informal el 18 de septiembre a la 1:20 p.m. hora del Este. Esta presentación se transmitirá en vivo y será accesible a través del sitio web de la empresa, con una repetición disponible durante aproximadamente 30 días.
Estas conferencias ofrecen a Organogenesis la oportunidad de mostrar su enfoque en el desarrollo, fabricación y comercialización de soluciones para los mercados de Cuidado Avanzado de Heridas y Medicina Quirúrgica y Deportiva.
Organogenesis Holdings (Nasdaq: ORGO), 선도적인 재생 의학 회사가 2024년 9월에 열리는 두 개의 투자자 회의에 참여한다고 발표했습니다. 회사는 다음과 같이 참석할 예정입니다:
1. 뉴욕, NY에서 열리는 Morgan Stanley Global Healthcare Conference에 참석하며, 경영진은 공식 발표 없이 투자자와의 1:1 미팅에 참여할 것입니다.
2. 뉴욕, NY에서 열리는 Cantor Fitzgerald Global Healthcare Conference에서는 9월 18일 오후 1시 20분(동부 표준시)에 진행되는 화기애애한 대화가 포함됩니다. 이 발표는 웹캐스트로 진행되며 회사 웹사이트를 통해 접근할 수 있으며, 약 30일 동안 다시 볼 수 있는 기능이 제공됩니다.
이 회의는 Organogenesis가 고급 상처 치료 및 수술 및 스포츠 의학 시장을 위한 제품 솔루션의 개발, 제조 및 상용화에 집중하고 있음을 보여줄 수 있는 기회를 제공합니다.
Organogenesis Holdings (Nasdaq: ORGO), une entreprise leader dans le domaine de la médecine régénérative, a annoncé sa participation à deux conférences pour investisseurs qui se dérouleront en septembre 2024. L'entreprise assistera :
1. À la Morgan Stanley Global Healthcare Conference à New York, NY, où la direction participera à des réunions individuelles avec des investisseurs sans présentation formelle.
2. À la Cantor Fitzgerald Global Healthcare Conference à New York, NY, qui comprendra un échange informel le 18 septembre à 13h20, heure de l'Est. Cette présentation sera diffusée en direct et accessible via le site Web de la société, avec un replay disponible pendant environ 30 jours.
Ces conférences offrent à Organogenesis l'occasion de mettre en avant son engagement envers le développement, la fabrication et la commercialisation de solutions pour les marchés des Soins Avancés des Plaies et de la Médecine Chirurgicale & Sportive.
Organogenesis Holdings (Nasdaq: ORGO), ein führendes Unternehmen im Bereich der regenerativen Medizin, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im September 2024 bekannt gegeben. Das Unternehmen wird teilnehmen:
1. An der Morgan Stanley Global Healthcare Conference in New York, NY, wo das Management an 1x1-Treffen mit Investoren ohne formelle Präsentation teilnehmen wird.
2. An der Cantor Fitzgerald Global Healthcare Conference in New York, NY, die am 18. September um 13:20 Uhr Eastern Time eine informelle Gesprächsrunde vorsieht. Diese Präsentation wird live gestreamt und kann über die Unternehmenswebsite abgerufen werden, mit einer Wiederholung, die etwa 30 Tage lang verfügbar sein wird.
Diese Konferenzen bieten Organogenesis die Möglichkeit, sein Engagement für die Entwicklung, Herstellung und Vermarktung von Produktlösungen für die Bereiche Fortgeschrittene Wundversorgung und Chirurgie & Sportmedizin zu präsentieren.
- None.
- None.
CANTON, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that management will participate in the following upcoming investor conferences:
The Morgan Stanley Global Healthcare Conference at the New York Marriott Marquis in New York, NY
- Management will participate in investor 1x1 meetings. There will be no formal presentation.
The Cantor Fitzgerald Global Healthcare Conference at the InterContinental Barclay Hotel in New York, NY
- Management will participate in a fireside chat on Wednesday, September 18 at 1:20 p.m. Eastern Time.
A webcast of the conference presentation will be accessible by visiting the “Upcoming Events” section on the “Investor Relations” page of Organogenesis’s website www.organogenesis.com. An archive of the webcast will be available for replay following the conference for approximately 30 days.
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care. For more information, visit www.organogenesis.com
FAQ
Which investor conferences will Organogenesis Holdings (ORGO) attend in September 2024?
When is Organogenesis Holdings' (ORGO) fireside chat at the Cantor Fitzgerald Global Healthcare Conference?
Will there be a webcast of Organogenesis Holdings' (ORGO) presentation at the Cantor Fitzgerald conference?
How long will the replay of Organogenesis Holdings' (ORGO) Cantor Fitzgerald conference presentation be available?
What markets does Organogenesis Holdings (ORGO) focus on?
